Free Trial

263,190 Shares in DocGo Inc. (NASDAQ:DCGO) Bought by First Eagle Investment Management LLC

DocGo logo with Medical background
Remove Ads

First Eagle Investment Management LLC acquired a new stake in DocGo Inc. (NASDAQ:DCGO - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 263,190 shares of the company's stock, valued at approximately $1,116,000. First Eagle Investment Management LLC owned 0.26% of DocGo as of its most recent SEC filing.

Other institutional investors have also recently bought and sold shares of the company. Centiva Capital LP bought a new stake in DocGo in the 3rd quarter valued at about $43,000. Intech Investment Management LLC bought a new stake in DocGo in the 3rd quarter valued at about $62,000. SG Americas Securities LLC boosted its holdings in DocGo by 12.9% in the 4th quarter. SG Americas Securities LLC now owns 43,052 shares of the company's stock valued at $183,000 after purchasing an additional 4,905 shares during the period. Victory Capital Management Inc. boosted its holdings in DocGo by 100.3% in the 3rd quarter. Victory Capital Management Inc. now owns 51,349 shares of the company's stock valued at $170,000 after purchasing an additional 25,714 shares during the period. Finally, Matrix Asset Advisors Inc. NY bought a new stake in DocGo in the 4th quarter valued at about $424,000. Institutional investors own 56.44% of the company's stock.

Analyst Upgrades and Downgrades

A number of analysts have recently weighed in on the stock. Stifel Nicolaus cut their price target on shares of DocGo from $6.50 to $5.50 and set a "buy" rating for the company in a report on Friday, February 28th. Deutsche Bank Aktiengesellschaft downgraded shares of DocGo from a "buy" rating to a "hold" rating and cut their price target for the stock from $5.00 to $2.85 in a report on Friday, February 28th. Finally, Needham & Company LLC cut their price target on shares of DocGo from $7.00 to $4.00 and set a "buy" rating for the company in a report on Friday, February 28th. One research analyst has rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus target price of $4.89.

Remove Ads

Check Out Our Latest Report on DocGo

DocGo Trading Down 2.1 %

NASDAQ:DCGO traded down $0.06 on Thursday, hitting $2.76. The company had a trading volume of 820,559 shares, compared to its average volume of 814,445. The stock has a market capitalization of $281.47 million, a price-to-earnings ratio of 9.86, a PEG ratio of 14.16 and a beta of 1.08. The firm has a 50 day moving average of $4.26 and a two-hundred day moving average of $3.97. DocGo Inc. has a 52 week low of $2.73 and a 52 week high of $5.68.

About DocGo

(Free Report)

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.

Further Reading

Institutional Ownership by Quarter for DocGo (NASDAQ:DCGO)

Should You Invest $1,000 in DocGo Right Now?

Before you consider DocGo, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocGo wasn't on the list.

While DocGo currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

5G Stocks: The Path Forward is Profitable Cover

Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report
Like this article? Share it with a colleague.
Remove Ads

Featured Articles and Offers

HIMS Stock Up 120%! More Growth Ahead?

HIMS Stock Up 120%! More Growth Ahead?

Hims & Hers (NYSE: HIMS) has skyrocketed 120% in just a month! Is it the next big disruptor in healthcare, or is it overpriced?

Recent Videos

 5 Stocks to BUY NOW in April 2025
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Time to Buy SoFi? Fintech’s Next Big Move

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines

Remove Ads